| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/14/2001 | WO2001041748A2 Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 06/14/2001 | WO2001041747A2 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating cancer |
| 06/14/2001 | WO2001041741A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 06/14/2001 | WO2001041704A2 Method for the prevention and/or treatment of atherosclerosis |
| 06/14/2001 | WO2001041701A2 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | WO2001041550A2 Topical anesthetic formulation |
| 06/14/2001 | WO2001041536A2 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001030811A3 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 06/14/2001 | WO2001019354A3 Composition for ivf |
| 06/14/2001 | WO2001018040A3 Use of leptin in inhibition of endothelial cell proliferation |
| 06/14/2001 | WO2001013904A3 Composition comprising a tramadol material and an anticonvulsant drug |
| 06/14/2001 | WO2001012128A3 Antibacterial agents for the treatment of acute mucosal infections |
| 06/14/2001 | WO2001009189A3 Compositions and methods for the treatment of tumors |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2000064441A3 Compound for use as a medicament for treatment of disorders involving bronchocontraction |
| 06/14/2001 | WO2000032631A3 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/14/2001 | CA2395039A1 Method for identifying inhibitors of cytokinesis |
| 06/14/2001 | CA2394060A1 Transmucosal administration of phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 06/14/2001 | CA2393779A1 Combination of compounds that inhibit the biological effects of tnf-.alpha. and cd95l in a medicament |
| 06/14/2001 | CA2393748A1 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 06/14/2001 | CA2393730A1 Hla class i a2 tumor associated antigen peptides and vaccine compositions |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393587A1 Use of an immunosuppressant for increasing an antifungal activity of a lipopeptide |
| 06/14/2001 | CA2393539A1 Radioactive compositions and methods of use thereof |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393470A1 The combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 06/14/2001 | CA2393141A1 Novel methods for the treatment and prevention of ileus |
| 06/14/2001 | CA2393045A1 Mutant er.alpha. and test systems for transactivation |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392742A1 T1 receptor-like ligand ii and uses thereof |
| 06/14/2001 | CA2392568A1 Method for the prevention and/or treatment of atherosclerosis |
| 06/14/2001 | CA2390093A1 Extracellular matrix and cell adhesion molecules |
| 06/14/2001 | CA2388959A1 Pharmaceutical combinations and their use in treating gastrointestinal disorders |
| 06/14/2001 | CA2388828A1 Topical anesthetic formulation |
| 06/14/2001 | CA2362815A1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 06/14/2001 | CA2362675A1 Polymorphic crystalline forms of celecoxib |
| 06/13/2001 | EP1107005A1 Method for identifying inhibitors of cytokinesis |
| 06/13/2001 | EP1107003A1 Methods for screening compounds active on neurons |
| 06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/13/2001 | EP1106184A2 Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications |
| 06/13/2001 | EP1106183A2 Antibodies to erbB2 and their therapeutic uses |
| 06/13/2001 | EP1105738A1 Assays, methods and means for modulating nuclear localisation |
| 06/13/2001 | EP1105734A2 Homer interacting proteins |
| 06/13/2001 | EP1105505A2 Compound and method for the prevention and/or the treatment of allergy |
| 06/13/2001 | EP1105504A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 06/13/2001 | EP1105501A2 Tpl-2/cot kinase and methods of use |
| 06/13/2001 | EP1105485A1 Human il-1 epsilon dna and polypeptides |
| 06/13/2001 | EP1105483A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 06/13/2001 | EP1105481A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 06/13/2001 | EP1105480A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105459A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 06/13/2001 | EP1105422A1 Hepatitis c inhibitor peptides |
| 06/13/2001 | EP1105418A1 Vanadate resistance glycosylation 4 gene |
| 06/13/2001 | EP1105411A1 nrdE |
| 06/13/2001 | EP1105391A2 New compounds |
| 06/13/2001 | EP1105390A2 New compounds |
| 06/13/2001 | EP1105389A1 Integrin receptor antagonists |
| 06/13/2001 | EP1105378A1 Quinazoline derivatives |
| 06/13/2001 | EP1105151A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105142A2 Blood-brain barrier therapeutics |
| 06/13/2001 | EP1105135A1 Antiviral indoleoxoacetyl piperazine derivatives |
| 06/13/2001 | EP1105134A2 Nalmefene in combination with opioid analgesics |
| 06/13/2001 | EP1105128A2 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105122A1 Pharmaceutical compositions containing lipase inhibitors |
| 06/13/2001 | EP1105112A2 Compositions and uses for vision and memory disorders |
| 06/13/2001 | EP1105101A2 Compositions and methods for treating intracellular infections |
| 06/13/2001 | EP1105097A2 Targeted vesicular constructs for cytoprotection and treatment of h.pylori infections |
| 06/13/2001 | EP1105094A1 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 06/13/2001 | EP1066402A4 Methods of screening agents for activity using teleosts |
| 06/13/2001 | DE19958985A1 Oligosaccharidmischung Oligosaccharide |
| 06/13/2001 | CN1299291A Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 06/13/2001 | CN1299290A High viscosity liquid controlled delivery system as a Device |
| 06/13/2001 | CN1299286A Use of protease inhibitors for treating skin wounds |
| 06/13/2001 | CN1299283A Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH |
| 06/13/2001 | CN1299279A Use of nicotinic receptor agonist |
| 06/13/2001 | CN1299276A CYP2A enzymes and their use in therapeutic and diagnostic method |
| 06/13/2001 | CN1299257A Use of corneal hardening agent in enzyme orthokeratology |
| 06/13/2001 | CN1298947A Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis inhibitor and its construction method |
| 06/13/2001 | CN1298743A Low-poison efficient antineoplastic medicine and its preparing process |
| 06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
| 06/12/2001 | US6245885 Bax-mediated apoptosis modulating reagents and methods |
| 06/12/2001 | US6245813 Use of ubenimex and the pharmaceutical composition containing it for treating virus hepatitis |
| 06/12/2001 | US6245808 Oxy-vanadium (IV) complexes having spermicidal activity |
| 06/12/2001 | US6245806 HIV integrase inhibitors |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245802 Method for treating pain |
| 06/12/2001 | US6245797 Administering mixture of enzyme inhibitors |
| 06/12/2001 | US6245789 HIV and viral treatment |
| 06/12/2001 | US6245788 Using 5-aryl-1,2,4-triadazol-3-yl (thio)urea compound |
| 06/12/2001 | US6245787 Composition containing amlodipine or a pharmaceutically acceptable salt thereof, and an ACE inhibitor |
| 06/12/2001 | US6245759 Tyrosine kinase inhibitors |
| 06/12/2001 | US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors; |
| 06/12/2001 | US6245736 Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease |
| 06/12/2001 | US6245563 Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor |
| 06/12/2001 | US6245362 Medication for treatment of viral disease based on active agents of plant hypericum (St. John's Wort) and method of production of the medication |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | US6245332 Modulation of systemic memory T cell trafficking |